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Optical diagnostics – spectropathology for the
next generation
This latest Optical Diagnosis themed
issue of Analyst, guest-edited by Prof.
Malgorzata Baranska, Jagiellonian Uni-
versity, Krakow, Poland, and Prof. Hugh
J. Byrne, Dublin Institute of Technology,
Ireland, is drawn from the participants
and proceedings of the International
conference, SPEC 2014: Shedding New
Light on Disease, which was held on the
17th–22nd August 2014 in Krakow,
Poland. The conference was co-chaired
by Prof. Baranska, Prof. Byrne and Prof.
Anna Sulkowska, Medical University of
Silesia, Katowice, Poland.
The event was the eighth in the series
of biennial conferences, the aim of
which is to bring together clinicians and
scientists who have joined forces in the
quest for novel biomedical applications
of infrared and Raman spectroscopy to
improve patient care. Recent advances in
the biological sciences and medicine
have led to an increasing demand for
real-time and minimally invasive chemi-
cal and structural information on bio-
logical materials. Due to its unique
fingerprinting capability, vibrational
spectroscopy plays a significant role in
histopathology, cytology, biopsy target-
ing, surgical targets, treatment-monitor-
ing and drug studies.
The conference aimed to highlight
further advances in state of the art and
emerging biomedical applications of
vibrational spectroscopy, while reviewing
the challenges in the context of other
emerging technologies. The programme
was constructed in an attempt to priori-
tise real-world applications from the
outset, systematically progressing from
research towards in-vivo, ex-vivo and
in-vitro applications, as well as emerging
technologies and data processing.
A feature of the conference was the
daily discussion sessions which were
aimed at a critical assessment of the
routes towards the further development
of clinical applications, and were
moderated by members of the SPEC
International Advisory Board. The delib-
erations are summarised in the second
editorial ‘Spectropathology for the next
generation: Quo vadis?’ (Byrne et al.,
c4an02036g), under the headings of
(i) Translational research into in-vivo
clinical applications, (ii) Ex-vivo tissue
biopsies, body fluids and cytological
samples for diagnostics and disease
studies, and (iii) In-vitro cell culture and
3D models for research and medical
applications. A number of critical con-
cerns are highlighted under the respect-
ive headings, including (i) the need for
the engagement with the clinical com-
munity and adherence to clinical stan-
dards in terms of statistical relevance,
(ii) standardisation of protocols for
sample preparation, presentation and
measurement and data processing, and
(iii) continued development of instru-
mentation and models to explore the
limitations of the techniques.
The scope of the conference and the
contents of this themed issue are indica-
tive of the progress in the understanding
of the complexity of spectroscopic
characterisation of biological materials,
and data preprocessing and postproces-
sing methods can increasingly be
applied with confidence to give true bio-
chemical representations of tissue, cells
and bodily fluids. The issue contains a
total of 51 contributed communications
and articles, drawing from research
activities across the globe, including
Australia, India, Japan, US and across
Europe with a notably strong represen-
tation from the host country, Poland.
The increased development of fibre
probes shows great promise for in-vivo
diagnosis and intra-operative appli-
cations, and although Raman probes –
operating at visible or near-infrared
wavelengths – are relatively well esta-
blished, probes for FTIR spectroscopy
are less so. The study by Padalkar and
Pleshko (c4an01987c) details the devel-
opment of such probes for the in-vivo
analysis of cartilage.
For clinical applications, the research
field remains dominated by ex-vivo appli-
cations of tissue, cells and biofluids.
Spectrohistopathological studies using
either FTIR or Raman profiling range
from analysis of cancer markers
in adrenal glands (Dudala et al.,
c4an01891e), salivary tissue (Brozek-
Pluska et al., c4an01394h), lung tumour
(Gerwert et al., c4an01978d), breast
tissue (Abramczyk et al., c4an01876a;
Brozek-Pluska et al., c4an01877j), and
primary and metastatic melanoma
(Wald and Goormaghtigh, c4an01831a).
Further studies include analysis of the
pituitary gland (Banas et al.,
c4an01985g), calcification of the aortic
valve (Kaczor et al., c4an01856g), the
vitamin A content in murine lung and
liver tissue (Marzec et al., c4an01881h;
Baranska et al., c4an01878h) and endo-
thelial function/dysfunction (Kaczor et al.,
c4an01870b; Rygula et al., c4an01998a).
Animal models also feature strongly in
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the studies of Chwiej et al. (c4an01857e)
as epileptic models, and as obesity
models in the work of Severcan et al.
(c4an02008a).
Cytological studies, using FTIR and
FTIR-ATR spectroscopy also feature
strongly, in, for example, the study by
Diem et al. (c4an01884b) of oesophageal
cells. Abramczyk et al. (c4an01875c)
demonstrate the role of lipid droplets
and adipocytes in cancer by comparing
the Raman spectral profiles of cell cul-
tures to those of adipocytes in cancerous
human breast tissue.
The contents of this issue reflect an
increasing prominence of studies of
blood cells (Wood et al., c4an01904k)
and peripheral blood lymphocytes
(Goormaghtigh et al., c4an01855a and
c4an02247e), and indeed of bodily fluids
themselves, using both FTIR and Raman
spectroscopy, notably blood plasma
(Šťovíčková et al., c4an01874e; Malek
et al., c4an01864h; Garnotel et al.,
c4an01942c; Tatarkovič et al., c4an01880j)
and serum (Chilakapati et al., c4an01860e),
potentially promising more accessible
routine screening applications of vibrational
spectroscopy.
Spectroscopic techniques remain a
powerful tool for basic research and may
find applications in vitro for toxicology
and drug screening, as exemplified by
the study of cellular uptake of doxorubi-
cin by Chlopicki, Baranska and co-
workers (c4an01882f), and the study of
the biocompatibility of nanocompo-
sites by Wesełucha-Birczyńska et al.
(c4an02284j), Malek et al. (c4an01988a),
and Campbell et al. (c4an02365j),
demonstrate the use of SERS-based
nanosensors to monitor the intracellular
pH in endothelial cells. Equally, such
in-vitro studies can provide valuable
explorations for new 3D cell culture
models (Smolina and Goormaghtigh,
c4an01833h), developing neural systems
(Sato et al., c4an01961j) and disease
models (malaria) (Hobro, Smith and co-
workers, c4an01850h). Mosig et al.
(c4an02153c) demonstrate the colocali-
zation of fluorescence and Raman micro-
scopic images for the identification of
subcellular compartments, and thus the
potential of the technique for in-vitro
screening.
Although the proof of concept of a
range of potential clinical applications
of vibrational spectroscopy has been well
demonstrated, there remains the need
for standardisation of measurement pro-
tocols and data processing, as high-
lighted in the discussion editorial (Byrne
et al., c4an02036g). Exploration of the
impact of tissue processing (Stone et al.,
c4an02122c; Wood et al., c4an02034k) as
well as measurement configurations for
FTIR spectroscopy (Gardner et al.,
c4an01975j; Mignolet and Goormaghtigh,
c4an01834f; Wood et al., c4an01901f;
Malek et al., c4an01842g) feature
strongly. Gardner et al. (c4an02053g)
also propose protocols for enhanced
FTIR bench-top imaging of single bio-
logical cells. The relative merit of
different classification and data-mining
algorithms continues to be a subject for
investigation (Wood et al., c4an01783h;
Surowka et al., c4an01867b; Gobinet
et al., c4an01937g; Diem et al.,
c4an01832j and c4an01879f; Meade
et al., c4an01887g), while Keating et al.
(c4an02167c) demonstrate the impor-
tance of simulated datasets for method
validation.
Emerging technologies continue to
push the performances in terms of
spatial resolution (Gough et al.,
c4an01982b), sampling depth (Ariese
et al., c4an01889c) and the emergence of
quantum cascade lasers as IR sources
promises increased scanning speeds for
large area spectral mapping (Kröger-Lui
et al., c4an02001d). Meanwhile, Czepiel,
Wesełucha-Birczyńska and co-workers
(c4an01947d) give glimpses into appli-
cations beyond human pathologies.
The field of clinical applications of
vibrational spectroscopy continues to
engage a broad interdisciplinary
research community across the world,
including spectroscopists, chemists, bio-
chemists etc. The field is furthermore
becoming increasingly intersectoral, as
instrument companies address the chal-
lenge of faster acquisition speeds over
larger areas, and the medical community
itself becomes more ‘spectrophilic’ and
engaged in promoting the potential of
spectropathology for the next generation.
We hope you find the articles gathered
in this themed issue of Analyst stimulat-
ing and inspiring.
Malgosia Baranska
Jagiellonian University, Krakow, Poland
Hugh J. Byrne
Dublin Institute of Technology, Ireland
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